Motixafortide Uses, Dosage, Side Effects and more
Motixafortide is under investigation in clinical trial NCT01838395 (Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML Patients).
| Trade Name | Motixafortide |
| Generic | Motixafortide |
| Motixafortide Other Names | Motixafortide |
| Type | |
| Formula | C97H144FN33O19S2 |
| Weight | Average: 2159.55 Monoisotopic: 2158.07417006 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
